Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Oncol.

Sec. Cancer Molecular Targets and Therapeutics

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1630547

KLF9 in Cancer: A Potential Prognostic Marker and Therapeutic Target

Provisionally accepted
  • 1Hunan Traditional Chinese Medical College, Zhuzhou, China
  • 2Binzhou Medical University, Yantai, China
  • 3Macau University of Science and Technology, Macau, Macao, SAR China

The final, formatted version of the article will be published soon.

Kruppel-like factor 9 (KLF9) is a transcription factor that has gained significant attention in recent years for its critical involvement in development and progression of various cancers. Recent research has revealed the dual nature in tumorigenesis, where KLF9 can function as either a tumor suppressor or an oncogene, depending on the cellular context. Clinically, KLF9 emerges as a potential prognostic biomarker due to its differential expression patterns across various cancer types, with lower KLF9 levels often correlating with poorer patient outcomes. Furthermore, KLF9 represents a promising therapeutic target, as modulating its activity may offer new strategies for cancer treatment. Overall, the present review provides new insights and perspectives for future research on KLF9 in cancer, underscoring its importance in personalized

Keywords: KLF9, Cancer, transcription factor, signaling pathway, Tumor Microenvironment, epigenetic modification, Therapeutic target

Received: 18 May 2025; Accepted: 21 Jul 2025.

Copyright: © 2025 Xiao, Zhipeng, Liu, Zhao and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xiaoxiao Xiao, Hunan Traditional Chinese Medical College, Zhuzhou, China
Qiang Wu, Macau University of Science and Technology, Macau, Macao, SAR China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.